Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02446600 |
Title | Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
Recruitment | Active, not recruiting |
Gender | female |
Phase | Phase III |
Variant Requirements | No |
Sponsors | National Cancer Institute (NCI) |
Indications |
fallopian tube serous adenocarcinoma peritoneal serous adenocarcinoma |
Therapies |
Carboplatin + Gemcitabine + Paclitaxel + Pegylated liposomal-doxorubicin |
Age Groups: | adult | senior |
Covered Countries | USA | CAN |